Skip to main content

White paper

New dimensions in life sciences research

Proving the impact on clinical outcomes as well as costs.

Using integrated data to create a dimensional view of outcomes and cost

Integrating data at scale is growing easier with advances in de-identification software, development of certified data models to protect privacy, and cloud-based computing. The resulting value is a dimensional view of outcomes and cost. Traditional analysis leaves vital information out of the value equation.

Improve decisions, enrich research and strengthen strategies

Life sciences research is benefiting from the powerful addition of integrated data. Researchers can now gain data in sufficient amounts to power robust analytics. This white paper explores how this new data can improve early business decisions, enrich research activity and strengthen market strategies.

Related healthcare insights

View all
Identifying Patients at Risk for Bone Fracture Within 2 Years

Case study

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Catalyze the Use of RWE in the Life Sciences Industry

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Trends Shaping Pharma Strategy in 2026 [E-book]

E-book

Trends shaping pharma strategy in 2026

How should pharma manufacturers strategically evolve as the industry shifts? Get expert insights from Advisory Board and Optum® Life Sciences.